Hakola K, Boogaart P V, Mulders J, de Leeuw R, Schoonen W, Heyst J V, Swolfs A, Casteren J V, Huhtaniemi I, Kloosterboer H
Department of Physiology, University of Turku, Finland.
Mol Cell Endocrinol. 1997 Apr 4;128(1-2):47-56. doi: 10.1016/s0303-7207(97)04018-5.
Rat recombinant (rec) luteinizing hormone (LH) was produced in Chinese hamster ovary (CHO) cells, to enable studies on LH physiology in this species with homologous hormone. The synthesized hormone was purified, and characterized physico-chemically and biologically in comparison with highly purified preparations of rat pituitary (pit) LH (NIDDK-rLH-I-7 and I-9) and to highly purified urinary (NIH, CR-121) and rec forms of human chorionic gonadotropin (hCG). The 33 kD molecular mass of rat recLH, as determined by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blot, was comparable with the 32 kD size of pitLH. In chromatofocusing, the isoforms of rat recLH distributed in the pI range 6.5-7.8, similar to rat pitLH. In receptor binding assays using rat testicular membranes, and physiologic salt concentration, rat recLH displayed a 5-10-fold higher affinity than rat pitLH, but about 100-fold lower affinity than hCG. In contrast, in low salt concentrations the affinities of rat recLH and rechCG to rat LH receptor were rather similar. The differences in potency in the mouse Leydig cell in vitro bioassay were in agreement with the receptor binding data at physiologic salt concentration. Neither rat recLH nor pitLH stimulated cAMP production or bound specifically to HEK 293 cells expressing the rec human LH receptor. When injected subcutaneously on four consecutive days to male rats (8.4-33.7 microg/rat/day) rat recLH did not induce seminal vesicle growth in comparison with a significant effect of human menopausal gonadotropin (hMG; 12.5-50 IU/rat/day). In contrast, ovulation was induced in 5/6 and 6/6 female rats following single injections of 3.75 and 7.5 microg of rat recLH, respectively, after pretreatment with 10 microg/kg of a GnRH-antagonist (Org 30850). In conclusion, rat recLH displays clearly lower in vivo and in vitro bioactivity than hCG. Nevertheless, it binds effectively to the rat LH receptor (with affinity dependent on salt concentration) and is bioactive in the mouse Leydig cell bioassay. This newly synthesized recombinant hormone provides a useful tool for further studies on the physiology of LH action in the rat, the most common animal model in reproduction research.
大鼠重组促黄体生成素(LH)在中国仓鼠卵巢(CHO)细胞中产生,以便使用同源激素研究该物种的LH生理学。合成的激素经过纯化,并与大鼠垂体(pit)LH的高度纯化制剂(NIDDK-rLH-I-7和I-9)以及人绒毛膜促性腺激素(hCG)的高度纯化尿液制剂(NIH,CR-121)和重组形式进行物理化学和生物学特性比较。通过SDS-聚丙烯酰胺凝胶电泳(SDS-PAGE)和蛋白质印迹法测定,大鼠重组LH的33 kD分子量与垂体LH的32 kD大小相当。在色谱聚焦中,大鼠重组LH的同工型分布在pI范围6.5-7.8,与大鼠垂体LH相似。在使用大鼠睾丸膜和生理盐浓度的受体结合试验中,大鼠重组LH显示出比大鼠垂体LH高5-10倍的亲和力,但比hCG低约100倍。相反,在低盐浓度下,大鼠重组LH和重组hCG对大鼠LH受体的亲和力相当相似。在小鼠睾丸间质细胞体外生物测定中的效力差异与生理盐浓度下的受体结合数据一致。大鼠重组LH和垂体LH均未刺激cAMP产生,也未与表达重组人LH受体的HEK 293细胞特异性结合。当连续四天皮下注射给雄性大鼠(8.4-33.7微克/大鼠/天)时,与人类绝经期促性腺激素(hMG;12.5-50国际单位/大鼠/天)的显著作用相比,大鼠重组LH未诱导精囊生长。相反,在分别用10微克/千克的GnRH拮抗剂(Org 30850)预处理后,单次注射3.75和7.5微克大鼠重组LH后,5/6和6/6的雌性大鼠诱导排卵。总之,大鼠重组LH在体内和体外的生物活性明显低于hCG。然而,它能有效地与大鼠LH受体结合(亲和力取决于盐浓度),并且在小鼠睾丸间质细胞生物测定中具有生物活性。这种新合成的重组激素为进一步研究LH在大鼠(生殖研究中最常用的动物模型)中的作用生理学提供了有用的工具。